Therefore, given that MMP-1, MMP-2, MMP-3, MMP-7, and MMP-10 have definitive contributions to the mucosal damage in IBD patients, a consideration of targeted MMPs treatment strategies is warranted in IBD [39]. This evidence concerns the gene MMP7 and inflammatory bowel disease.